Arax Advisory Partners’s Quest Diagnostics DGX Stock Holding History

Arax Advisory Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$896K	Buy	4,228 +3,495	+477%	+$686K	0.01%	1275
2026 Q1	$141K	Sell	733 -287	-28%	-$55.8K	﹤0.01%	1233
2025 Q4	$177K	Sell	1,020 -2,104	-67%	-$383K	0.01%	1089
2025 Q3	$595K	Buy	3,124 +2,623	+524%	+$465K	0.01%	843
2025 Q2	$90K	Buy	501 +61	+14%	+$10.6K	﹤0.01%	979
2025 Q1	$74.4K	Buy	440 +416	+1,733%	+$68.3K	﹤0.01%	816
2024 Q4	$3.62K	Sell	24 -22	-48%	-$3.42K	﹤0.01%	1850
2024 Q3	$7.14K	Buy	46 +21	+84%	+$3.14K	﹤0.01%	1552
2024 Q2	$3.42K	Buy	+25	New	+$3.42K	﹤0.01%	1756
2020 Q1	–	Sell	-51	Closed	-$5K	–	685
2019 Q4	$5K	Hold	51	–	–	﹤0.01%	514
2019 Q3	$5K	Hold	51	–	–	﹤0.01%	511
2019 Q2	$5K	Buy	+51	New	+$4.9K	﹤0.01%	514
2018 Q4	$4K	Hold	51	–	–	﹤0.01%	500
2018 Q3	$6K	Sell	51 -19	-27%	-$2.08K	﹤0.01%	513
2018 Q2	$7K	Hold	70	–	–	﹤0.01%	363
2018 Q1	$7K	Hold	70	–	–	﹤0.01%	346
2017 Q4	$6K	Hold	70	–	–	﹤0.01%	353
2017 Q3	$6K	Sell	70 -46	-40%	-$4.88K	﹤0.01%	356
2017 Q2	$13K	Buy	116 +46	+66%	+$4.86K	0.01%	328
2017 Q1	$6K	Hold	70	–	–	﹤0.01%	348
2016 Q4	$6K	Buy	+70	New	+$6.03K	﹤0.01%	345

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Arax Advisory Partners's DGX Position: Q2 2026 in Review

Arax Advisory Partners increased its Quest Diagnostics (DGX) stake by 477% in Q2 2026, buying an estimated $686K and bringing the position to 4,228 shares worth $896K. The position accounts for 0.01% of the portfolio, ranked #1275.

Arax Advisory Partners first reported a position in DGX in Q4 2016 and has held it in 21 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Arax Advisory Partners held 4,228 shares of Quest Diagnostics worth $896K as of Q2 2026.
Arax Advisory Partners bought 3,495 Quest Diagnostics shares in Q2 2026, an estimated $686K.
Quest Diagnostics made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1275 holding.
Arax Advisory Partners first reported a position in Quest Diagnostics in Q4 2016 and has held it in 21 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.